Publication | Closed Access
Phase I Trial of Technetium [Leu<sup>13</sup>] Bombesin as Cancer Seeking Agent: Possible Scintigraphic Guide for Surgery?
47
Citations
16
References
2002
Year
99mTc BN is able to clearly image tumors with BN receptor overexpression. Our first impression is that in the future this radiopharmaceutical may serve as a cancer seeking agent and, due to its high tumoral uptake, also as a radiotracer for radioisotope-guided surgery.
| Year | Citations | |
|---|---|---|
Page 1
Page 1